Paul Hastings Advised Jasper Therapeutics in $103.5 Million Public Offering

Paul Hastings LLP advised Jasper Therapeutics in its underwritten public offering of 69,000,000 shares of common stock. The gross proceeds from this offering are approximately $103.5 million before deducting underwriting discounts, commissions, and other offering expenses.

Partners Jeff Hartlin and Samantha Eldredge led the Paul Hastings team, which also included associates Jenna Barba, Rose Lu, and Youssef Aziz.

More details on the transaction can be found here.